vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and PLAYSTUDIOS, Inc. (MYPS). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $55.4M, roughly 1.5× PLAYSTUDIOS, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -24.7%, a 47.5% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs -18.3%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $3.6M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -15.6%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
PLAYSTUDIOS, Inc. develops and publishes free-to-play social and casual casino games for mobile, desktop and social platforms. It operates a loyalty rewards program that lets players redeem in-game achievements for real-world benefits including travel, dining and event tickets, serving markets across North America, Europe and Asia Pacific.
FDMT vs MYPS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $55.4M |
| Net Profit | $19.4M | $-13.7M |
| Gross Margin | — | — |
| Operating Margin | 17.3% | -17.7% |
| Net Margin | 22.8% | -24.7% |
| Revenue YoY | 8508900.0% | -18.3% |
| Net Profit YoY | 139.1% | 38.9% |
| EPS (diluted) | $0.43 | $-0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $55.4M | ||
| Q3 25 | $90.0K | $57.6M | ||
| Q2 25 | $15.0K | $59.3M | ||
| Q1 25 | $14.0K | $62.7M | ||
| Q4 24 | $1.0K | $67.8M | ||
| Q3 24 | $3.0K | $71.2M | ||
| Q2 24 | $5.0K | $72.6M | ||
| Q1 24 | $28.0K | $77.8M |
| Q4 25 | $19.4M | $-13.7M | ||
| Q3 25 | $-56.9M | $-9.1M | ||
| Q2 25 | $-54.7M | $-2.9M | ||
| Q1 25 | $-48.0M | $-2.9M | ||
| Q4 24 | — | $-22.4M | ||
| Q3 24 | $-43.8M | $-3.1M | ||
| Q2 24 | $-35.0M | $-2.6M | ||
| Q1 24 | $-32.4M | $-567.0K |
| Q4 25 | 17.3% | -17.7% | ||
| Q3 25 | -67983.3% | -13.6% | ||
| Q2 25 | -396373.3% | -5.9% | ||
| Q1 25 | -383007.1% | -4.4% | ||
| Q4 24 | — | -33.1% | ||
| Q3 24 | -1704400.0% | -6.7% | ||
| Q2 24 | -849120.0% | -5.5% | ||
| Q1 24 | -136200.0% | -2.2% |
| Q4 25 | 22.8% | -24.7% | ||
| Q3 25 | -63195.6% | -15.8% | ||
| Q2 25 | -364386.7% | -5.0% | ||
| Q1 25 | -342657.1% | -4.6% | ||
| Q4 24 | — | -33.1% | ||
| Q3 24 | -1461433.3% | -4.3% | ||
| Q2 24 | -699060.0% | -3.6% | ||
| Q1 24 | -115717.9% | -0.7% |
| Q4 25 | $0.43 | $-0.12 | ||
| Q3 25 | $-1.01 | $-0.07 | ||
| Q2 25 | $-0.98 | $-0.02 | ||
| Q1 25 | $-0.86 | $-0.02 | ||
| Q4 24 | — | $-0.18 | ||
| Q3 24 | $-0.79 | $-0.02 | ||
| Q2 24 | $-0.63 | $-0.02 | ||
| Q1 24 | $-0.66 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $104.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $227.9M |
| Total Assets | $566.7M | $290.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $104.9M | ||
| Q3 25 | $305.1M | $106.3M | ||
| Q2 25 | $293.2M | $112.9M | ||
| Q1 25 | $321.4M | $107.1M | ||
| Q4 24 | $424.9M | $109.2M | ||
| Q3 24 | $501.9M | $105.2M | ||
| Q2 24 | $541.9M | $106.3M | ||
| Q1 24 | $525.9M | $127.0M |
| Q4 25 | $505.7M | $227.9M | ||
| Q3 25 | $369.0M | $238.9M | ||
| Q2 25 | $420.9M | $245.3M | ||
| Q1 25 | $469.7M | $244.1M | ||
| Q4 24 | $510.6M | $244.7M | ||
| Q3 24 | $552.9M | $265.2M | ||
| Q2 24 | $588.3M | $263.6M | ||
| Q1 24 | $600.6M | $288.4M |
| Q4 25 | $566.7M | $290.6M | ||
| Q3 25 | $424.0M | $299.2M | ||
| Q2 25 | $473.6M | $316.2M | ||
| Q1 25 | $515.7M | $313.8M | ||
| Q4 24 | $560.4M | $323.0M | ||
| Q3 24 | $604.0M | $330.6M | ||
| Q2 24 | $620.1M | $333.4M | ||
| Q1 24 | $629.9M | $357.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $3.7M |
| Free Cash FlowOCF − Capex | $28.5M | $3.6M |
| FCF MarginFCF / Revenue | 33.5% | 6.5% |
| Capex IntensityCapex / Revenue | 0.1% | 0.2% |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $25.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $3.7M | ||
| Q3 25 | $-46.5M | $5.7M | ||
| Q2 25 | $-43.4M | $13.6M | ||
| Q1 25 | $-47.8M | $3.3M | ||
| Q4 24 | $-134.6M | $11.6M | ||
| Q3 24 | $-29.4M | $14.6M | ||
| Q2 24 | $-30.2M | $14.5M | ||
| Q1 24 | $-29.1M | $5.0M |
| Q4 25 | $28.5M | $3.6M | ||
| Q3 25 | $-46.6M | $5.4M | ||
| Q2 25 | $-43.4M | $13.2M | ||
| Q1 25 | $-48.4M | $3.2M | ||
| Q4 24 | $-138.4M | $11.5M | ||
| Q3 24 | $-31.2M | $13.9M | ||
| Q2 24 | $-30.6M | $12.8M | ||
| Q1 24 | $-29.8M | $3.6M |
| Q4 25 | 33.5% | 6.5% | ||
| Q3 25 | -51765.6% | 9.3% | ||
| Q2 25 | -289620.0% | 22.3% | ||
| Q1 25 | -345635.7% | 5.1% | ||
| Q4 24 | -13837100.0% | 16.9% | ||
| Q3 24 | -1038966.7% | 19.6% | ||
| Q2 24 | -611840.0% | 17.6% | ||
| Q1 24 | -106421.4% | 4.6% |
| Q4 25 | 0.1% | 0.2% | ||
| Q3 25 | 101.1% | 0.5% | ||
| Q2 25 | 440.0% | 0.7% | ||
| Q1 25 | 4507.1% | 0.2% | ||
| Q4 24 | 378600.0% | 0.2% | ||
| Q3 24 | 59266.7% | 0.9% | ||
| Q2 24 | 6980.0% | 2.4% | ||
| Q1 24 | 2535.7% | 1.9% |
| Q4 25 | 1.47× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
